source
- Oruka's yearly injectable shows 63% complete clearance in mid-stage psoriasis trialOruka Therapeutics reported results from a Phase 2 trial of its long-acting injectable, ORKA-001, in patients with plaque psoriasis. In the study, 63% of participants achieved complete skin cleara…
- Supreme Court split on blocking thousands of Roundup cancer lawsuitsThe Supreme Court heard arguments on Monday about whether to block thousands of lawsuits claiming the weedkiller Roundup caused cancer, and the justices appeared divided. The dispute follows a wav…